Sanofi Hits Rare Setback For Dupixent In Urticaria
Therapy Failed To Control Itch
The French major has hit a rare roadblock in the onward march of its anti-inflammatory blockbuster.
The French major has hit a rare roadblock in the onward march of its anti-inflammatory blockbuster.